Quality Product Research: Proposed rating for Financial Planning & Legal Advice

Introduction

We have recently conducted a full review on our “Financial Planning & Legal Advice” item. Please find the new sub-items below.

Proposed sub-items

FInancial final

Notes

The Financial Planning & Legal Advice benefit differs between insurers with a significant weighting on whether the company offers reimbursement on legal expenses. Fidelity is one of the major insurers who doesn’t offer this, and customers are only eligible for payment if their Life cover sum insured is over $100,000. Similarly, Momentum Life requires 3 years continuous cover before payment eligibility.

Another item worth mentioning is Asteron, Fidelity and Westpac directly stating that the benefit will be paid out to all policy owners – the maximum amount paid by most insurers is $2,500 so this particularly feature seems to reduce the value of the benefit.  

Your feedback

We value getting your feedback on how these wordings are being applied to claims you may be aware of. Please email us with details of any recent claims to help us update our understanding.

Doreen Dutt, Research Analyst, Quality Product Research Limited, researcher@qpresearch.co.nz


Quality Product Research: Proposed rating for Coma (Trauma)

Introduction

Following on with our recent theme of revising ratings, we have reviewed Coma, re-assessing the item based on modern definitions.  A rarely claimed on benefit, yet significant coverage in the media when the insurer decides not to pay out.  

Below are the proposed items for Coma.

Coma

Notes

Momentum life is the only provider that requires the insured to be in a coma for 96-hours, while Westpac uniquely requires a permanent neurological deficit. Three insurers, Fidelity, Pinnacle and Westpac specifically exclude medically induced comas and a similar definition is observed in the use of life support systems and response to internal and external needs.

Few insurers continue to use the Glasgow Coma Scale in their definitions – here is a quick overview of what the scale demonstrates https://medictests.com/units/glasgow-coma-score

Your feedback

We value getting your feedback on how these wordings are being applied to claims you may be aware of. Please email us with details of any recent claims to help us update our understanding.

Doreen Dutt, Research Analyst, Quality Product Research Limited, researcher@qpresearch.co.nz


Quality Product Research: Proposed rating for Benign Brain and Spine Tumour

Introduction

The World Health Organisation states that 130 different types of brain tumours exist. A benign brain tumour is a non-cancerous growth in a distinct area of the brain. The survival rates for patients with benign brain tumours are higher than others, however this depends on the size and location of the tumour within the brain.

Proposed sub-items

Capture

Notes

There are some noticeable differences between insurers such as whether partials exist, or if the spinal cord or tumour on the pituitary gland is covered. We have tried to make the sub-items clearly demonstrate the variation between insurers.

Why is this important?

Although QPRs weighting of this item is low, it would be of high interest to those that have a family history of brain cancers. With a lot of insurers now having specialised cancer products we would like to ensure that our rating is relevant. 

Your feedback

We value getting your feedback on how these wordings are being applied to claims you may be aware of. Please email us with details of any recent claims to help us update our understanding.

Doreen Dutt, Research Analyst, Quality Product Research Limited, researcher@qpresearch.co.nz


Recent Product Updates

QPR subscribers have just received the latest database version (138) it is also live on Quotemonster, the changes in this version include:

* Cigna - new policy document 11/11/2020 -  rating changes applied

* Unimed - new policy document 01/08/2020 -  rating changes applied

* AA Health - new policy document nib366402 and nib366401 effective 01/05/2019 -  rating changes applied

* ANZ Life and Living - new policy document A0006 effective 31/01/2020 -  rating changes applied

* Momentum Life: - New policy document for Life 2633-MLPL2-PW 22/10/2020, New policy document for funeral 2667-MLF6-PW 21/09/2020 - Rating changes applied

* Revised view on: Medical - Treatment (overseas)


How do I offend thee? Let me count the ways....

In an awful appropriation of a line from a beautiful Elizabeth Barret Browning poem, I shall ask "How do I offend thee, let me count the ways..." as the headline for thinking about advertising.

A friend of my wife's think the Momentum Life advert featuring nude middle aged people is in poor taste. Oh no, not for her the need to be reminded that skin is not so toned, nor body quite so pert, as it once was. This was slightly surprising, because at other times this person is not afraid of being forthright, or engaging in bawdy humour. But I must not digress.

A key axis of tension in marketing is between these two ideas:

  • Show images your audience will identify with, but might be a bit too realistic
  • Show images your audience will aspire to, but might be a bit too unrealistic

You can be criticised for only showing beautiful people, or people of just one type, or only thin people, or...

You can be criticised for showing too much reality - older people with average bodies, people not speaking perfectly, mess, vox-pops etc...

As an advertiser, using a medium that reaches many people, only one thing is certain: you will be criticised.

I actually think the Momentum Life adverts were quite good. In some respects, very good. The cliche of 'shopping naked' is an obvious reference for a company wishing to highlight its ease of application process. A further reference may be to the exposure that one feels when completing application forms, something Momentum rarely requires.